Clinical Trial Update: Pharmacokinetic Study of BMS-914143 in Participants With Normal Renal Function and Mild, Moderate, Severe and End-stage Renal Dysfunction [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study of BMS-914143 in participants with normal renal function and mild to end-stage renal dysfunction; the study has completed to chara…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B
• Hepatitis C

Drugs mentioned

• BMS-914143

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Chronic Hepatitis B Virus Infection, Chronic Hepatitis C Virus Infection | Phase 1 | Status: COMPLETED